Formulation | Tablet strength | |||
---|---|---|---|---|
Pediatric formulation | Adult formulation | |||
AQ | AS | AQ | AS | |
Loose NFDC | - | - | 200Â mg | 50Â mg |
Co-blistered NFDC | - | - | 153Â mg | 50Â mg |
FDC (Trimalact®) | - | - | 300 mg | 100 mg |
FDC (Coarsucam®/Winthrop®) | 67.5 mg | 25 mg | 270 mg | 100 mg |
135Â mg | 50Â mg |